Explore more publications!

Press Releases

SEALSQ to Demonstrate Its Post-Quantum Technology in Robotics With WISeRobot.ch’s First Proof of Concept at a Davos Roundtable
To His Excellency Mr. Guy Parmelin, President of the Swiss Confederation

To His Excellency Mr. Guy Parmelin, President of the Swiss Confederation

Trends and Demand in Thermoformed Trays Market 2025-35
Automotive Logistics Market is expected to generate a revenue of USD 634.26 Billion by 2030, Globally, at 6.3% CAGR: Verified Market Research®
GENFIT: Favorable Phase 1 Safety Profile and Strong Anti-Inflammatory Activity for ACLF Lead Asset G1090N   
Pharmaceutical Bottles Market Report for Packaging Companies
Medical Second Opinion Market to Reach US$12.7B by 2031 at 14.8% CAGR, North America Leads with 45%
Dietary Supplements Market Size Expected to Reach USD 430.39 Bn by 2034 Driven by Preventive Healthcare, Personalized Nutrition, and Rising Health Awareness
Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
Global Precision Medicine Market Growth Accelerates at 16.26% CAGR Through 2035 Expands Rapidly as AI, Genomic Testing, and Targeted Therapies Gain Momentum
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
Frozen Yogurt Market Set to Reach USD 11.53 Billion by 2035, Driven by Health Trends and Flavor Innovation
Medical Devices Market Size Worth USD 1,209.42 Bn by 2035 Fueled by Advances in Diagnostic Technologies
Generic Pharmaceuticals Contract Manufacturing Market to Reach USD 143.22 Billion by 2035, Driven by Demand for Affordable Therapies
Mainz Biomed Provides Review of 2025 Highlights
Idorsia’s daridorexant in women during menopausal transition age with insomnia
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions